Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease

The occurrence of a noninfectious interstitial lung disease is a rare but life-threatening side effect of infliximab, an antitumor necrosis factor alpha antibody. The following case report of a patient with Crohn disease shows an extremely dramatic progression to a severe acute respiratory distress...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoehl, Johanna, Mechie, Nicolae-Catalin, Schwoerer, Harald, Moerer, Onnen, Quintel, Michael, Buck, Cordula, Ellenrieder, Volker, Neesse, Albrecht, Amanzada, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121573/
https://www.ncbi.nlm.nih.gov/pubmed/27920644
http://dx.doi.org/10.1159/000450676
Descripción
Sumario:The occurrence of a noninfectious interstitial lung disease is a rare but life-threatening side effect of infliximab, an antitumor necrosis factor alpha antibody. The following case report of a patient with Crohn disease shows an extremely dramatic progression to a severe acute respiratory distress syndrome.

Ejemplares similares